Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕ICICI Prudential Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundICICI Prudential Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaICICI Pru
NAV₹591.2429₹25.6900
NAV date20 Nov 202619 Nov 2026
History—5.8 years
Expense ratio1.8%1.8%
StarsNot rated★★★★★
Growth Score—77.50

Returns

Nippon India Pharma FundICICI Prudential Business Cycle Fund
1 month—+10.02%
3 months—+3.63%
6 months—+6.82%
YTD—−0.16%
1 year—−0.19%
3 years (CAGR)—+15.23%
5 years (CAGR)—+14.54%
10 years (CAGR)——
Since launch—+17.53%

Risk

Nippon India Pharma FundICICI Prudential Business Cycle Fund
Volatility—15.0%
Downside volatility—9.8%
Sharpe—0.58
Sortino—0.89
Calmar—1.03
Return / risk—1.02
Deepest fall—−14.74%
Days to recover—118
Below its high—−1.50%

Against benchmark

Nippon India Pharma FundICICI Prudential Business Cycle Fund
Alpha—+3.13%
Beta—0.90
R²—92.7%
Up capture—99.9%
Down capture—82.7%
Tracking error—4.4%
Information ratio—0.59
Treynor—0.08

Consistency

Nippon India Pharma FundICICI Prudential Business Cycle Fund
Best 1-year—+56.26%
Middle 1-year—+12.61%
Worst 1-year—−10.53%
1-year periods with a loss—5.0%
Middle 3-year—+22.02%
Positive months—61.1%
Best day—+4.47%
Worst day—−5.44%
Worst 5% day—−1.25%
Positive days—54.8%
NAVs a year—247

SIP of ₹10,000 a month

Nippon India Pharma FundICICI Prudential Business Cycle Fund
5-year XIRR—+14.12%
5-year value—₹8,60,368
3-year XIRR—+8.23%
1-year XIRR—+7.14%

Holdings overlap i

Nippon India Pharma FundICICI Prudential Business Cycle Fund
Nippon India Pharma Fund—0%
ICICI Prudential Business Cycle Fund0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Sectors and company size

Nippon India Pharma FundICICI Prudential Business Cycle Fund
Large companies——
Mid companies——
Small companies——
Top 10 holdings57.2%45.4%
Largest sectorPharmaceuticals & Biotechnology 75%Banks 22%

Search Growth